[ Inglés] MPN Research: It Takes a Village to Make a Difference

Published on

Topics include: Treatments and Understanding

What has MPN research gained from widespread attention to this relatively rare group of diseases? Dr. Ruben Mesa, a leading researcher, discusses the shift in focus over the last several decades, and why he is "tremendously hopeful" about recent efforts. Dr. Mesa explains that because MPN research could serve as a proving ground for other cancers, people with MPNs will benefit from their time in the spotlight.

View more programs featuring

Related Programs

Advances in Understanding and Treating MPNs

Dr. Srdan Verstovsek, a world-renowned researcher from MD Anderson Cancer Center, explores what he describes as "unprecedented developments" in the understanding of myeloproliferative neoplasms (MPNs) and how new research could lead to more effective treatment.


Exciting Data on Developing Drugs for Myelofibrosis

Over the past year, there has been continued progress in improving treatments for myelofibrosis. Watch now as Dr. Claire Harrison shares updated news from the Comfort II study, including how patients are responding to the treatment regimen with few side effects.


How Combination Therapies With JAK Inhibitors May Change MPN Treatment

Will JAK inhibitors make a difference for polycythemia vera (PV) and essential thrombocythemia (ET) patients? How significant are they in treating myelofibrosis? Watch now as Dr. Francisco Cervantes shares his perspecitve on how this class of drugs may be used alone or in combination to improve MPN outcomes.


Únete a Nuestra Comunidad Regístrate para Eventos Lee Nuestro Último Post

Page last updated on January 22, 2014